within Pharmacolibrary.Drugs.V_Various.V10A_AntiinflammatoryAgents.V10AX05_Rhenium186reSulfideColloid;
model Rhenium186reSulfideColloid 
   extends Pharmacolibrary.Drugs.ATC.V.V10AX05;

  annotation(Documentation(
    info ="<html><body><p>Rhenium (186Re) sulfide colloid is a radioactive therapeutic agent used primarily for radionuclide synovectomy to treat chronic inflammatory joint diseases such as rheumatoid arthritis. It is administered intra-articularly, delivering localized radiation to inflamed synovial tissue. It is used in some countries for radiosynovectomy procedures, but is not approved as a drug in all jurisdictions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult patients receiving intra-articular injection for synovectomy. No published population PK models or comprehensive pharmacokinetic data specific to this colloid could be found.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Rhenium186reSulfideColloid;
